T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report released on Wednesday morning. The firm issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Down 4.3 %

Shares of TTOO stock opened at $0.22 on Wednesday. The stock has a fifty day moving average of $0.39 and a 200 day moving average of $1.84. T2 Biosystems has a 52 week low of $0.22 and a 52 week high of $6.95.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.